These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17488690)

  • 1. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology.
    Aessopos A; Kati M; Farmakis D
    Haematologica; 2007 May; 92(5):658-65. PubMed ID: 17488690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in beta-thalassemia.
    Aessopos A; Farmakis D
    Ann N Y Acad Sci; 2005; 1054():342-9. PubMed ID: 16339682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management.
    Farmakis D; Triposkiadis F; Lekakis J; Parissis J
    Eur J Heart Fail; 2017 Apr; 19(4):479-489. PubMed ID: 28000341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure in beta-thalassemia syndromes: a decade of progress.
    Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
    Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac involvement in thalassemia intermedia: a multicenter study.
    Aessopos A; Farmakis D; Karagiorga M; Voskaridou E; Loutradi A; Hatziliami A; Joussef J; Rombos J; Loukopoulos D
    Blood; 2001 Jun; 97(11):3411-6. PubMed ID: 11369631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart disease in thalassemia intermedia.
    Aessopos A; Tsironi M; Andreopoulos A; Farmakis D
    Hemoglobin; 2009; 33 Suppl 1():S170-6. PubMed ID: 20001622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
    Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
    Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.
    Aessopos A; Farmakis D; Deftereos S; Tsironi M; Tassiopoulos S; Moyssakis I; Karagiorga M
    Chest; 2005 May; 127(5):1523-30. PubMed ID: 15888823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.
    Aessopos A; Berdoukas V
    Mediterr J Hematol Infect Dis; 2009 Jul; 1(1):e2009002. PubMed ID: 21415984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac involvement in beta-thalassaemia: current treatment strategies.
    Paul A; Thomson VS; Refat M; Al-Rawahi B; Taher A; Nadar SK
    Postgrad Med; 2019 May; 131(4):261-267. PubMed ID: 31002266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the cardiovascular complications of thalassemia by echocardiography.
    Walker JM; Nair S
    Ann N Y Acad Sci; 2010 Aug; 1202():165-72. PubMed ID: 20712789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia.
    Aessopos A; Stamatelos G; Skoumas V; Vassilopoulos G; Mantzourani M; Loukopoulos D
    Chest; 1995 Jan; 107(1):50-3. PubMed ID: 7813310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
    Asadov C; Alimirzoeva Z; Mammadova T; Aliyeva G; Gafarova S; Mammadov J
    Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-thalassemia intermedia: a clinical perspective.
    Musallam KM; Taher AT; Rachmilewitz EA
    Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a013482. PubMed ID: 22762026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better survival and less cardiac morbidity in female patients with thalassemia major: a review of the literature.
    Marsella M; Pepe A; Borgna-Pignatti C
    Ann N Y Acad Sci; 2010 Aug; 1202():129-33. PubMed ID: 20712783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a novel mechanism independent of myocardial iron in β-thalassemia cardiac pathogenesis.
    Stoyanova E; Cloutier G; Felfly H; Lemsaddek W; Ah-Son N; Trudel M
    PLoS One; 2012; 7(12):e52128. PubMed ID: 23284899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload in β-thalassemia intermedia: an emerging concern.
    Musallam KM; Cappellini MD; Taher AT
    Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between cardiac magnetic resonance T2* and left ventricular global longitudinal strain in people with β-thalassemia.
    Parsaee M; Akiash N; Azarkeivan A; Alizadeh Sani Z; Amin A; Pazoki M; Samiei N; Jalili MA; Adel MH; Rezaian N
    Echocardiography; 2018 Apr; 35(4):438-444. PubMed ID: 29399871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.